Monday, October 06, 2008

Correction on Indevus share price jump

I just realised that my post is probably not telling the whole story about Indevus' share price jump, because on the same day, they released information on another compound which this article by Anuradha Ramanathan claims has provoked the jump:

Shares of Indevus Pharmaceuticals more than doubled after the company reached a deal with U.S. health regulators to use its existing data for an early re-application seeking marketing approval for its testosterone replacement drug.

The agreement with the U.S. Food and Drug Administration removes the need for more studies and Indevus now plans to apply again for marketing approval in the first quarter of 2009, and launch the drug in the fourth quarter, the company said in a statement.

4 comments:

Olivier said...

http://fr.youtube.com/watch?v=ZG9PkRTnkuY

(just announce, in french)

Scott said...

Can anyone interpret please?

Olivier said...

Nothing news...the girl said that "we're going to see the very first drug for stuttering...at the end, it's cool not to have only speech therapist to treat persons who stutters..."

Scott said...

Thanks Olivier!